There is not enough space on Twitter to thank all the amazing people who contributed to this paper. But I have to try....
nature.com/articles/s4146…
Joshua Meeks
2,438 posts
Joshua Meeks
@JoshMeeks
Urologic Oncologist and Scientist at Northwestern University
K-index:3.7
- Here’s our @EUplatinum paper just published online- first in human phase I trial of intravesical pembro for BCG unresponsive bladder cancer Small trial- huge effort @RHLCC, @Merck , @nanostringtech Khyati Meghani @dgpnorthwestern , @SvatekRob sciencedirect.com/science/articl…
- Great to see S1011 abstract for @ASCO . Congrats to S1011 team. @slernerbcmedu1 @siadaneshmand @SvatekRob @ecskinner53 @UroDocAsh @WesKassouf @AnneSchuckmanMD @montypal @SWOG @SupportingSWOG meetings.asco.org/abstracts-pres…
- I couldn’t be more proud of our lab’s first major paper- comparing human bladder cancer to BBN Mouse model. No model is perfect- but we think there’s a reason this model has persisted over 40 years. @NCIgenomics. nature.com/articles/s4138…
- The next wave is coming. Get ready. Congrats @UIowa_urology @VigneshPackiam. Looking forward to the ph IIII @MaxKates @eugene_pietzak
- Super excited that our review on T1 bladder cancer published in @NatRevUrol. We tried to pack as much as could. Bottom line: a lot more work to do on the clinical and translational sides for risk stratification and treatment #bladdercancer nature.com/articles/s4158…
- One of my favorite things about spring is our annual visiting professor. Now named after Anthony J Schaeffer. This year we hosted James Eastham from @MSKCancerCenter. @NM_Urology.
00:00- Ever wonder why NMIBCs respond (or don't) to pembrolizumab? We did, too! Here is our spatial analysis comparing identifying stromal and epithelial signatures of response to IV and intravesical pembrolizumab.
- Here is the disease-free survival, shown by pCR and non-pCR from Niagara. #AUA2025
